Campbell & Co. Investment Adviser »

Royalty Pharma shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.4M 95k 25.51
2024-09-30 $2.2M 77k 28.29
2024-03-31 $747k 25k 30.37
2023-06-30 $307k 10k 30.74

More positions owned by Campbell & Co. Investment Adviser

Intercontinental Exchange In Common Stock (ICE)
Fastenal Common Stock (FAST)
Novartis Adr (NVS)
Hca Healthcare Common Stock (HCA)
Schwab Charles Corp Common Stock (SCHW)
Electronic Arts Common Stock (EA)
Elevance Health Common Stock (ELV)
Grainger W W Common Stock (GWW)
Packaging Corp Amer Common Stock (PKG)
Roper Technologies Common Stock (ROP)
Mondelez Intl Common Stock (MDLZ)
Aflac Common Stock (AFL)
Applied Matls Common Stock (AMAT)
Marketaxess Hldgs Common Stock (MKTX)
Ameriprise Finl Common Stock (AMP)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
FMR
BlackRock
Adage Capital Partners GP
Baillie Gifford & Co
Viking Global Investors
Swedbank AB
State Street Corporation
Geode Capital Management
Norges Bank Investment Management
Two Sigma Advisers
Northern Trust
GMT Capital Corp
Deutsche Bank Aktiengesellschaft

View all funds holding Royalty Pharma